Panel approves HIV prevention drug

In a report by the BBC, a US drug panel recommends the FDA to approve the drug Truvada. The pill would be used by people at high risk of contracting the HIV virus.

The panel voted nineteen to three in favour of prescribing the drug to high risk patients.

Certain health workers and groups active in HIV community are opposed to the drug and want the FDA to reject it, however, correspondents say that this drug could help a big deal in the fight against HIV.

The FDA will make its decision by June 15.

Flickr Photo by: Pranjal Mahna